Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 908668 | ISIN: US0311001004 | Ticker-Symbol: AK1
Tradegate
15.01.25
09:30 Uhr
174,96 Euro
+1,04
+0,60 %
Branche
Elektrotechnologie
Aktienmarkt
S&P 500
1-Jahres-Chart
AMETEK INC Chart 1 Jahr
5-Tage-Chart
AMETEK INC 5-Tage-Chart
RealtimeGeldBriefZeit
173,08175,0209:53
173,08175,0209:53
PR Newswire
134 Leser
Artikel bewerten:
(0)

AMETEK, Inc.: AMETEK Announces Second Quarter Results

Finanznachrichten News

BERWYN, Pa., Aug. 1, 2024 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30, 2024.

AMETEK's second quarter 2024 sales were $1.73 billion, a 5% increase over the second quarter of 2023. Operating income increased 7% to a record $447.5 million and operating margins were 25.8%, up 40 basis points from the second quarter of 2023. Operating cash flow in the quarter was $381.4 million, up 14% versus the prior year.

On a GAAP basis, second quarter earnings per diluted share were $1.45. Adjusted earnings in the quarter were $1.66 per diluted share, up 6% from the second quarter of 2023. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.21 per diluted share. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.

"Our operating performance in the second quarter was strong with outstanding core margin expansion, record operating income and EBITDA, and earnings growth ahead of our expectations," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "We also generated excellent cash flows, with free cash flow up 17% and free cash flow conversion of 107% in the quarter. These results reflect the strength and flexibility of our operating model as well as our team's ability to successfully manage through a slower growth environment."

Electronic Instruments Group (EIG)
EIG sales in the second quarter were $1.15 billion, up 2% from the same quarter in 2023. EIG's operating income in the quarter increased 14% to $349.9 million with operating income margins of 30.3%, an increase of 320 basis points compared to the second quarter of 2023.

"EIG delivered strong results this quarter with excellent operating performance leading to outstanding profit growth and robust margin expansion," stated Mr. Zapico. "Our EIG businesses are well positioned across a diverse set of attractive market segments."

Electromechanical Group (EMG)
EMG sales in the second quarter were a record $581.2 million, up 14% from the second quarter of 2023. EMG's second quarter operating income was $123.1 million, while operating income margins were 21.2% in the quarter.

"EMG continued to experience headwinds in the quarter from the normalization of inventory levels across our OEM customer base," stated Mr. Zapico. "Despite these headwinds, our teams delivered solid operating performance with sequential margins improving 50 basis points versus the first quarter's adjusted margins."

2024 Outlook
"Our operating results through the first half of 2024 have been solid against the backdrop of a slower growth environment. We now expect the impact of inventory normalization within our OEM customer base will continue through the balance of 2024. Additionally, customers are turning more cautious leading to some short-term delays in project spending," stated Mr. Zapico.

"As a result, we are adjusting our sales and earnings guidance for the year," continued Mr. Zapico. "We remain confident in our ability to successfully manage through these near-term demand headwinds, deliver strong operating performance and cash flows, and ensure AMETEK is well positioned for strong growth and profitability."

"For 2024, we now expect overall sales to be up between 5% and 7% compared to 2023. Adjusted earnings per diluted share, including a lower tax rate in the fourth quarter, are now expected to be in the range of $6.70 to $6.80, up 5% to 7% over the comparable basis for 2023," he added.

"For the third quarter of 2024, overall sales are expected to be up mid-single digits on a percentage basis compared to the same period last year. Adjusted earnings in the quarter are anticipated to be in the range of $1.60 to $1.62, down 1% to 2% compared to the third quarter of 2023," concluded Mr. Zapico.

Conference Call
AMETEK will webcast its second quarter 2024 investor conference call on Thursday, August 1, 2024, beginning at 8:30 AM ET. The live audio webcast will be available and later archived in the Investors section of www.ametek.com.

About AMETEK
AMETEK (NYSE: AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for over 90 years and is a component of the S&P 500. For more information, visit www.ametek.com.

Forward-looking Information
Statements in this news release relating to future events, such as AMETEK's expected business and financial performance are "forward-looking statements." Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include risks related to AMETEK's ability to consummate and successfully integrate future acquisitions; risks with international sales and operations, including supply chain disruptions; AMETEK's ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Forms 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Contact:
Kevin Coleman
Vice President, Investor Relations and Treasurer
[email protected]
Phone: 610.889.5247

AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)

(Unaudited)



Three Months Ended
June 30,


Six Months Ended
June 30,


2024


2023


2024


2023

Net sales

$ 1,734,834


$ 1,646,111


$ 3,471,014


$ 3,243,228









Cost of sales

1,110,425


1,053,190


2,255,106


2,075,715

Selling, general and administrative

176,895


174,130


351,178


343,181

Total operating expenses

1,287,320


1,227,320


2,606,284


2,418,896

Operating income

447,514


418,791


864,730


824,332

Interest expense

(30,590)


(18,723)


(65,844)


(39,292)

Other (expense) income, net

86


(3,684)


(547)


(9,057)

Income before income taxes

417,010


396,384


798,339


775,983

Provision for income taxes

79,327


72,142


149,713


146,029

Net income

$ 337,683


$ 324,242


$ 648,626


$ 629,954









Diluted earnings per share

$ 1.45


$ 1.40


$ 2.79


$ 2.72

Basic earnings per share

$ 1.46


$ 1.41


$ 2.80


$ 2.74









Weighted average common shares outstanding:








Diluted shares

232,304


231,261


232,170


231,245

Basic shares

231,437


230,478


231,267


230,302









Dividends per share

$ 0.28


$ 0.25


$ 0.56


$ 0.50

AMETEK, Inc.

Information by Business Segment

(In thousands)

(Unaudited)



Three Months Ended

June 30,


Six Months Ended

June 30,


2024


2023


2024


2023

Net sales:








Electronic Instruments

$ 1,153,613


$ 1,134,646


$ 2,310,392


$ 2,251,893

Electromechanical

581,221


511,465


1,160,622


991,335

Consolidated net sales

$ 1,734,834


$ 1,646,111


$ 3,471,014


$ 3,243,228









Operating income:








Segment operating income:








Electronic Instruments

$ 349,857


$ 307,052


$ 702,797


$ 616,799

Electromechanical

123,102


136,215


213,793


256,719

Total segment operating income

472,959


443,267


916,590


873,518

Corporate administrative expenses

(25,445)


(24,476)


(51,860)


(49,186)

Consolidated operating income

$ 447,514


$ 418,791


$ 864,730


$ 824,332

AMETEK, Inc.

Condensed Consolidated Balance Sheet

(In thousands)



June 30,


December 31,


2024


2023


(Unaudited)



ASSETS




Current assets:




Cash and cash equivalents

$ 396,573


$ 409,804

Receivables, net

976,442


1,012,932

Inventories, net

1,101,719


1,132,471

Other current assets

292,510


269,461

Total current assets

2,767,244


2,824,668





Property, plant and equipment, net

861,577


891,293

Right of use asset, net

217,469


229,723

Goodwill

6,453,513


6,447,629

Other intangibles, investments and other assets

4,496,063


4,630,220

Total assets

$ 14,795,866


$ 15,023,533





LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




Short-term borrowings and current portion of long-term debt, net

$ 827,967


$ 1,417,915

Accounts payable and accruals

1,375,080


1,464,658

Total current liabilities

2,203,047


2,882,573





Long-term debt, net

1,823,410


1,895,432

Deferred income taxes and other long-term liabilities

1,517,005


1,515,337

Stockholders' equity

9,252,404


8,730,191

Total liabilities and stockholders' equity

$ 14,795,866


$ 15,023,533

AMETEK, Inc.

Reconciliations of GAAP to Non-GAAP Financial Measures

(In thousands, except per share amounts)

(Unaudited)



Three Months Ended


June 30,


2024


2023





Diluted earnings per share (GAAP)

$ 1.45


$ 1.40

Pretax amortization of acquisition-related intangible assets

0.27


0.22

Income tax benefit on amortization of acquisition-related intangible assets

(0.06)


(0.05)

Adjusted Diluted earnings per share (Non-GAAP)

$ 1.66


$ 1.57





Cash provided by operating activities (GAAP)

$ 381,435


$ 335,247

Deduct: Capital expenditures

(21,416)


(27,829)

Free cash flow (Non-GAAP)

$ 360,019


$ 307,418





Free Cash Flow Conversion (Free cash flow divided by net income)

107 %


95 %


Forecasted Diluted Earnings Per Share


Three Months Ended


Year Ended


September 30, 2024


December 31, 2024


Low


High


Low


High









Diluted earnings per share (GAAP)

$ 1.39


$ 1.41


$ 5.78


$ 5.88

Paragon integration costs

-


-


0.13


0.13

Income tax benefit on Paragon integration costs

-


-


(0.03)


(0.03)

Pretax amortization of acquisition-related intangible assets

0.27


0.27


1.08


1.08

Income tax benefit on amortization of acquisition-related intangible assets

(0.06)


(0.06)


(0.26)


(0.26)

Adjusted Diluted earnings per share (Non-GAAP)

$ 1.60


$ 1.62


$ 6.70


$ 6.80

Use of Non-GAAP Financial Information
The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles ("GAAP") basis with certain non-GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non-GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.

The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEK's operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.

SOURCE AMETEK, Inc.

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.